Astellas Pharma Inc. http://www.alacrastore.com/company-snapshot/Astellas_Pharma_Inc-1020359 Monday, September 08, 2008 3:17:44 AM 1020359 Astellas Pharma Inc. en AlacraStore RSS Builder 1.0 30 US - APP Pharmaceuticals agreed to acquire the Grand Island, New York plant of Astellas Pharma Inc, a manufacturer and wholesaler of pharmaceuticals.9/6/2008 9:28:38 AM00202H04466J00202H04667MAPP Pharmaceuticals IncAstellas Pharma Inc-Grand Island,New York PlantAPP Pharmaceuticals IncAstellas Pharma Inchttp://www.alacrastore.com/storecontent/Thomson_M%26A/APP_Pharmaceuticals_Inc_acquires_Astellas_Pharma_New_York_Plant_from_Astellas_Pharma_Inc-2009748020sdc/20097480202009748020Copyright © 2008, Thomson Financial, All Rights ReservedNasdaqDrugsUnited StatesPharmaceutical preparations2834ILIllinoisPublicAPPX2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundries2834:Pharmaceutical preparations5122:Drugs, drug proprietaries, and druggists' sundriesDrugsUnited StatesPharmaceutical preparations2834NYNew YorkSubsidiary118675002Mnfr,whl pharm prodMnfr,whl pharmUnspecifiedAssets1038573001Sep 6 20080.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.00000APP Pharmaceuticals Inc,located in Schaumburg,Illinois, manufactures,wholesales and marketsinjectable pharmaceuticalproducts with a primary focuson the oncology, antiinfective,anesthetic/analgesic andcritical care markets. Thecompany was founded in 1996.APP Pharmaceuticals Inc, located in Schaumburg, Illinois,manufactures, wholesales and markets injectablepharmaceutical products with a primary focus on theoncology, anti infective, anesthetic/analgesic and criticalcare markets. The company was founded in 1996.APP Pharmaceuticals Inc, located in Schaumburg, Illinois, manufactures, wholesales and markets injectable pharmaceutical products with a primary focus on the oncology, anti infective, anesthetic/analgesic and critical care markets. The company was founded in 1996.1.000002.00000Grand Island, New York plantof Astellas Pharma.Grand Island, New York plant of Astellas Pharma.Grand Island, New York plant of Astellas Pharma.0.000000.000000.000000.00000N04 Sep 08Thu, 04 Sep 2008 00:00:00 ESTDate Announced: 09/04/2008Date Effective:Acq. of AssetsFriendly0.000000.000000.000000.000000.000000.00000Price/Share0.0000000.000000.0000000.000000.000000.000000.000000.000000.0000000.00000N0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000100.000000.000000.000000.000000.000000.000000.000000.000000.000003711.091000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000001.000002.000003.000004.000005.000006.00000US - APP Pharmaceuticalsagreed to acquire the GrandIsland, New York plant ofAstellas Pharma Inc, amanufacturer and wholesaler ofpharmaceuticals.US - APP Pharmaceuticals agreed to acquire the Grand Island, New York plant of Astellas Pharma Inc, a manufacturer and wholesaler of pharmaceuticals.US - APP Pharmaceuticals agreed to acquire the Grand Island, New York plant of AstellasPharma Inc, a manufacturer and wholesaler of pharmaceuticals.US - APP Pharmaceuticals agreed to acquire the Grand Island, New York plant of Astellas Pharma Inc, a manufacturer and wholesaler of pharmaceuticals.US - APP Pharmaceuticals agreed to acquire the Grand Island, New York plant of Astellas Pharma Inc, a manufacturer and wholesaler ofpharmaceuticals.Pending0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.00000Status:Pending-999.00000np0.00000-999.00000np0.000000.000000.000000.000000.000000.000000.000000.000000.000000.000000.000002833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances118675002NasdaqUnited States2834IllinoisPublicAPPX2833:Medicinal chemicals and botanical products2834:Pharmaceutical preparations2836:Biological products, except diagnostic substances5122:Drugs, drug proprietaries, and druggists' sundries6573002Tokyo 1Japan2834ForeignPublic45030.000000.000000.000000.00000Deal InformationThomson Financial Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/bir/1198990bir/1198990normAstellas Pharma Inc.JapanManufacturing: Manufacture of pharmaceuticals: antibiotics, metabolic drugs, circulatory system agents.283428333254123254119IL45038/26/2008 6:21:37 AM1198990Company Profiles & FinancialsGale Company Profileshttp://www.alacrastore.com/storecontent/ccbn/T1895609ccbn/T1895609norm...All of you, hello, and welcome to the conference call of first quarter financial results fiscal year ending March #### of Astellas Pharma Incorporated. ... 8/1/2008 6:06:00 PMAstellas Pharmaceutical54.0000FinalAstellas Pharmaceutical Q1 2009 Earnings Conference Call (English) Transcript4503.JP5:00pm JTTranscriptT1895609Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1822335ccbn/T1822335norm... - Astellas Pharmaceutical - President and CEO Good morning. I am President and CEO Nogimori. Thank you very much for coming over to this venue, despite the adverse weather. So, the focus of my presentation is the business results for fiscal year ####. Before I go into the slides let me just say a word.Yesterday, for the fiscal year #### results, we have been able to see a great increase in both sales and profit. However, on the other hand for fiscal year ####, for various reasons, unfortunately we are forecasting a decline in sales and profit. So under this situation, as the management through the sales promotion of new products and investment in R&D and we can be sure that these fruits will be contributing, I'd like to link this to our future growth. So I will be asking for your unremitted support. So let me get into the presentation. First of all I would like to give you an overview of fiscal year ####. As for the whole performance, I will go into detail from the next slide onwards.... 5/15/2008 9:05:00 AMAstellas Pharmaceutical54.0000FinalFull Year 2008 Astellas Pharmaceutical Earnings Conference Call (English) Transcript4503.JP10:45am JTTranscriptT1822335Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1737267ccbn/T1737267normQ# #### Astellas Pharmaceutical Earnings Conference Call (English)2/1/2008 11:08:00 AMAstellas Pharmaceutical54.0000FinalQ3 2008 Astellas Pharmaceutical Earnings Conference Call (English) Transcript4503.JP6:30pm JTTranscriptT1737267Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1714794ccbn/T1714794norm12/31/2007 5:21:41 PMAstellas Pharmaceutical54.0000FinalAstellas Pharmaceutical R&D Meeting - Conference Call (English) Transcript4503.JP3:30pm JT...Hello and welcome to the conference call of the R&D meeting of Astellas Pharma. The conference call today is held based on presentation materials available at the Company's website. And we may suggest that you visit our website to see the presentation materials on the display, if you don't have yet it's printed copies in your hand. (OPERATOR INSTRUCTIONS). This conference call is being recorded and we're beginning the conference. Once again ladies and gentlemen, we will now begin the conference. ... TranscriptT1714794Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1705717ccbn/T1705717norm12/31/2007 5:21:33 PMAstellas Pharmaceutical54.0000FinalAstellas US Holding, Inc. (an Astellas Pharmaceutical subsidiary) to Acquire Agensys, Inc. Conference Call (English) Transcript4503.JP6:30pm JT...Good evening this is [Okamara] from Astellas. Thank you very much for joining the Astellas teleconference in spite of your busy schedule. Now we'd like to discuss the acquisition of Agensys which is a biotech company in the US and that was announced -- the news was announced in [#.##] today. And attendees include Dr. Tamura, Executive Vice President, and Dr. [Kato] Molecular Medicine Research Lab Head and [Okamra] and (inaudible) from accounting, and Dr. Tamura will give the presentation. ... TranscriptT1705717Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1665393ccbn/T1665393norm11/7/2007 11:07:00 AMAstellas Pharmaceutical54.0000FinalInterim 2008 Astellas Pharmaceutical Earnings Conference Call (English) Transcript4503.JP10:30am JT... - Astellas Pharmaceutical - President and CEO Ladies and gentlemen, good morning. I am Masafumi Nogimori, President and CEO of Astellas Pharmaceutical. Today, thank you for coming over to our presentation despite your busy schedule. And I would also like to extend my gratitude to the support that you have shown us. Today I would like to announce the First Half financial results for fiscal ####, which we announced yesterday. (inaudible) to give you the outline of this half. You can see this in this slide shown here, Page #. This First Half, compared to the previous year, we have been able to achieve increases in both sales and profits. (inaudible) these global products has been able to show growth. Cost-of-sales ratio, compared to the previous year, has improved. On top of that, R&D expenses have declined substantially. In June, in the U.K. and Germany we have launched-- The MR combination of Advagraf has been released. In Japan, we launched Celecox. In October, again in Japan, we launched... TranscriptT1665393Credit & Investment ResearchThomson Street Events